A20 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of A20 monoclonal antibodies for investigating A20 protein activity in cellular processes. A20 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). A20 protein functions as a critical regulator of inflammation and immune responses by negatively regulating NF-κB signaling. Understanding A20 protein activity is essential for maintaining immune homeostasis and preventing excessive inflammatory responses that can lead to autoimmune diseases. A20 protein has emerged as an important focus in cancer research, highlighting its potential as a therapeutic target. Researchers utilizing A20 monoclonal antibodies can explore cellular signaling pathways and their impact on disease progression. Advanced research techniques supported by A20 monoclonal antibodies enable detailed examination of protein interactions and expression patterns. Investigating A20 protein mechanisms contributes to developing new therapeutic strategies for inflammatory and autoimmune conditions. Santa Cruz Biotechnology monoclonal antibodies for A20 protein support researchers worldwide in advancing scientific understanding of immune regulation and disease pathology.